Kenacomb Ointment tube

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Aktív összetevők:

gramicidin, Quantity: 0.25 mg/g; triamcinolone acetonide, Quantity: 1 mg/g; nystatin, Quantity: 100000 U/g; neomycin sulfate (Equivalent: neomycin, Qty 2.5 mg/g)

Beszerezhető a:

Aspen Pharmacare Australia Pty Ltd

Gyógyszerészeti forma:

Ointment

Összetétel:

Excipient Ingredients: polyethylene; liquid paraffin

Az alkalmazás módja:

Topical

db csomag:

30g, 15g

Osztály:

Medicine Registered

Recept típusa:

(S4) Prescription Only Medicine

Terápiás javallatok:

KENACOMB is indicated for the relief of the inflammatory and pruritic manifestations of dermatoses likely to become or which are already infected.

Termék összefoglaló:

Visual Identification: A yellow to amber coloured ointment.; Container Type: Tube; Container Material: Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Engedélyezési státusz:

Registered

Engedély dátuma:

1991-09-30

Betegtájékoztató

KENACOMB OINTMENT- Consumer Medicine Information
Page 1 of 4
KENACOMB
OINTMENT
_triamcinolone acetonide, nystatin, gramicidin & neomycin (as sulfate)
_
CONSUMER MEDICINE INFORMATION (CMI)
WHAT IS IN THIS LEAFLET
This leaflet answers some
common questions about
KENACOMB ointment. It does not
contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
ALWAYS FOLLOW THE INSTRUCTIONS
THAT YOUR DOCTOR OR PHARMACIST
GIVE YOU ABOUT KENACOMB
OINTMENT.
ASK YOUR DOCTOR OR PHARMACIST IF
YOU HAVE ANY CONCERNS ABOUT
USING THIS MEDICINE.
DO NOT THROW THIS LEAFLET AWAY.
You may need to refer to it again
later.
WHAT KENACOMB
OINTMENT IS USED FOR
KENACOMB ointment is used to
relieve the inflammation and
itching of skin conditions which are
likely to become infected or are
already infected.
KENACOMB is an ointment
containing a combination of the
following medicines:
• _triamcinolone acetonide_, belongs
to a class of drugs called
corticosteroids, which helps to
relieve itching, inflammation and
redness.
• _neomycin_, is an antibacterial
medicine
• _gramicidin_, is an antibacterial
medicine
• _nystatin,_ is an antifungal drug. It
is used to prevent or treat a
particular type of fungal infection
called _Candida albicans_.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY
KENACOMB OINTMENT HAS BEEN
PRESCRIBED FOR YOU.
Your doctor may have prescribed
it for another purpose.
This medicine is available only
with a doctor’s prescription.
For external use only.
_USE IN CHILDREN: _
KENACOMB ointment should be
used carefully in children. Using it
long term or on large areas of skin
can cause systemic side effects
through absorption of the
ointment.
_ _
_ _
BEFORE YOU USE IT
_WHEN YOU MUST NOT USE IT _
DO NOT USE KENACOMB
OINTMENT IF YOU HAVE AN ALLERGY
TO:

any medicine containing
nystatin, neomycin,
gramicidin, triamcinolone
acetonide

any of the ingredients listed at
the end of this leaflet.
Some of the symptoms of an
allergic reaction may include:

shortness of breath


Termékjellemzők

1
AUSTRALIAN PRODUCT
I
NFO
R
MAT
I
O
N
KENACOMB
(TRIAMCINOLONE ACETONIDE; NYSTATIN; NEOMYCIN (AS SULFATE) AND
GRAMICIDIN)
OINTMENT
1
NAME OF THE MEDICINE
Triamcinolone acetonide; nystatin; neomycin (as sulfate) and
gramicidin.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
KENACOMB ointment for topical use contains triamcinolone acetonide 1
mg (0.1%), neomycin (as
sulfate) 2.5 mg, gramicidin 0.25 mg and nystatin 100,000 IU per gram.
For the full list of excipients, see Section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
KENACOMB ointment is a yellow to amber coloured ointment.
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
KENACOMB is indicated for the relief of the inflammatory and pruritic
manifestations of dermatoses
likely to become or which are already infected.
4.2
D
OSE AND METHOD OF ADMINISTRATION
Apply to the affected area 2 to 3 times daily.
4.3
C
ONTRAINDICATIONS
Known hypersensitivity to triamcinolone, neomycin, nystatin or
gramicidin.
Ophthalmic use.
Tuberculous lesions and most viral lesions of the skin such as Herpes
simplex, but particularly in
vaccinia and varicella.
4.4
S
PECIAL WARNINGS AND PRECAUTIONS FOR USE
GENERAL
If sensitivity or irritation develops, use of this medication should
be discontinued and appropriate therapy
instituted. Hypersensitivity reactions to the anti-infective
components may be masked by the presence
of a corticosteroid.
Because of the potential hazard of nephrotoxicity and ototoxity, this
medication should not be used in
patients with extensive skin damage or other conditions where
absorption of neomycin is possible.
2
The use of occlusive dressing should be avoided because of the
increased risk of sensitivity reactions
and increased percutaneous absorption particularly of triamcinolone
acetonide and neomycin.
As with any antibiotic preparation, prolonged use may result in
overgrowth of nonsusceptible organisms,
including fungi other than Candida. Corticosteroids, furthermore, can
enhance microbial infections.
Therefore constant observation of the patient is essenti